Insightra Medical, Inc.

IRVINE, CA · CIK 0001606764 · Medtech · Acquired

Cardiovascular medical devices

insightra.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$20M
4 Form D · Aug 2015
134 months since last filing
Contracts
$9K
1 award · Veterans Affairs
#633 of 4531 in medtech
Patents
18
6 granted · 12 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$6,000,000
Private capital raisedForm D · SEC$6,125,000
Private capital raisedForm D · SEC$2,837,500
Private capital raisedForm D · SEC$5,000,000
Federal contractDepartment of Veterans Affairs · Surgical Implants - Abdominal Meshs$9,176
Federal contract · USAspendingForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
630CREOSALUS INC.$10K—
631ADVANCED CYTOMETRY INSTRUMENTATION SYSTEMS LLC$10K—
632InCellDx, Inc.$10K$9.5M
633Insightra Medical, Inc.$9K$20M
634OSMIC ENTERPRISES, INC.$9K—
635BIOVENTURES, INC$7K—
636Biofrontera Inc.$6K$58M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 13 related persons
  • Steve BellExecutive Officer
  • Frank GentileDirector
  • Shane JohnsonDirector
  • Laximant KhanolkarExecutive Officer
  • Laxmikant KhanolkarExecutive Officer
  • Michael LiangDirector
  • John MarkovichExecutive Officer
  • Rajesh MoortiDirector
  • Wayne NodaExecutive Officer
  • Daniel OmsteadDirector
  • Amit ShahExecutive Officer
  • Brad SharpDirector · Executive Officer
  • Bradley SharpDirector · Executive Officer

Patents

USPTO · 6 granted of 18

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.